Use of Wearable Digital Sensors After mRNA Vaccination in Adults

Completed

Conditions studied: Healthy Participants

In brief

The purpose of this study is to explore the physiological and behavioral impact of the immune response to vaccines after receipt of investigational or approved messenger ribonucleic acid (mRNA) vaccines using wearable medical sensors, with the potential of establishing a digital biomarker of vaccine response due to stimulation of the immune system.

Key facts

Study ID

NCT05440318

Run by

ModernaTX, Inc.

People needed

62

Starts

2022-06-16

Expected to finish

2023-02-07

Last updated by the study team

2023-04-04

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Enrolled in a concurrent Moderna-sponsored vaccine clinical trial.
• Investigator assessment that participant understands and is willing and physically able to comply with wearing the sensors and follow-up as outlined in the study protocol, including all procedures.
• Participant has provided written informed consent for participation in this study, including all evaluations and procedures as specified in the study protocol.

You may not qualify if…

• History of hypersensitivity or allergic reaction to medical adhesive or other history of skin irritation, that, in the opinion of the investigator, contraindicates their use of a wearable medical device.
• Broken skin at the site of wearable location
• Implanted, permanent pacemaker

Where it is running

• Johnson County Clinical Trials — Lenexa, Kansas, United States
• Meridian Clinical Research — Lincoln, Nebraska, United States
• Benchmark Research — Austin, Texas, United States
• DM Clinical Research- Texas Center for Drug Development — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.